How is Acute myelogenous leukemia (AML) diagnosed?

TL;DR: Acute myelogenous leukemia (AML) is diagnosed through a combination of blood tests, bone marrow biopsies, and specialized genetic analysis to identify abnormal myeloid cells. Because Acute myelogenous leukemia (AML) can progress rapidly, a prompt diagnosis by a hematologist-oncologist is critical to initiate life-saving treatment.

How is Acute myelogenous leukemia (AML) diagnosed?

The diagnostic process for Acute myelogenous leukemia (AML) typically begins when a complete blood count (CBC) shows abnormal levels of red blood cells, white blood cells, or platelets. To confirm the diagnosis, specialists perform a bone marrow aspiration and biopsy, usually from the hip bone. These samples are analyzed using flow cytometry to identify specific surface markers on cells and cytogenetic testing to detect chromosomal abnormalities, which are essential for classifying the disease according to World Health Organization (WHO) criteria.

What tests are essential for confirming the disease?

Accurate diagnosis requires a multi-faceted approach to distinguish Acute myelogenous leukemia (AML) from other blood disorders. Key diagnostic procedures include:

• Peripheral blood smear: Microscopic examination to look for "blasts" (immature leukemia cells).


• Bone marrow biopsy: Essential to confirm that at least 20% of the cells in the marrow are blasts.


• Cytogenetic analysis: Used to identify specific chromosomal translocations that influence treatment.


• Molecular testing: Genetic sequencing to look for mutations in genes such as FLT3, NPM1, or CEBPA.

Which specialists manage the diagnosis of Acute myelogenous leukemia (AML)?

The diagnosis is typically made by a hematopathologist in conjunction with a hematologist-oncologist. While primary care doctors may suspect the condition, the complexity of Acute myelogenous leukemia (AML) necessitates referral to a specialized cancer center. We recognize the frustration of the "diagnostic odyssey," but because this condition requires urgent intervention, seeking a center of excellence is vital to ensure an accurate subtype classification.

What conditions can mimic Acute myelogenous leukemia (AML)?

Differential diagnosis is crucial because other conditions can present similarly, including acute lymphoblastic leukemia (ALL), severe vitamin B12 deficiency, or myelodysplastic syndromes (MDS). Misdiagnosis can delay appropriate therapy, which is why the 62 members of our DiseaseMaps.org community often emphasize the importance of second opinions at academic medical centers.

Next steps

• Consult a board-certified hematologist-oncologist immediately if your blood counts are abnormal.


• Request copies of your flow cytometry and genetic testing reports for your personal medical records.


• Join the DiseaseMaps community to connect with others who have navigated the path to an Acute myelogenous leukemia (AML) diagnosis.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• National Cancer Institute (NCI) - AML Treatment Overview


• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Acute Myeloid Leukemia


• Leukemia & Lymphoma Society (LLS) - Understanding AML